Last updated on March 2019

To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Foam 0.005%/0.064% in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis).


Brief description of study

A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Calcipotriene and Betamethasone Dipropionate Topical Foam, 0.005%/0.064% (Glenmark Pharmaceuticals Ltd) to the Marketed Product Enstilar Foam (LEO Pharma Inc.) in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis)

Clinical Study Identifier: NCT03731091

Find a site near you

Start Over

Investigational Site 21

Saint Joseph, MO United States
2.71miles
  Connect »